KEZAR LIFE SCIENCES, INC.
Profile
Company Names
KEZAR LIFE SCIENCES, INC.
Addresses
300 UTAH AVENUE, SUITE 105, SOUTH SAN FRANCISCO, CA 94080
Phone Numbers
650-463-4052
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$78,369,107.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2017-06-26
$49,999,985.00
$49,999,985.00
$0.00
Equity
1
2015-06-11
$28,369,122.00
$28,369,122.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANKLIN
BERGER
DIRECTOR
FIVE PRIME THERAPEUTICS INC
| ITHERX PHARMA, INC.
| IMMUNE DESIGN CORP.
| ALZHEON, INC.
| ATRECA, INC.
| ESSA PHARMA INC.
| CERUS ENDOVASCULAR LTD
| KEZAR LIFE SCIENCES, INC.
| BELLUS HEALTH INC.
| APPLIED THERAPEUTICS INC.
| ATEA PHARMACEUTICALS, INC.
| RAIN THERAPEUTICS INC.
| WALKING FISH THERAPEUTICS, INC.
| SATELLOS BIOSCIENCE INC.
GERALD
CHAN
DIRECTOR
CRITICAL BIOLOGICS CORP
| MORNINGSIDE CHINA TMT FUND II, L.P.
| SYNCHRONEURON INC.
| NATURAL POLYMER INTERNATIONAL CORP
| APELLIS PHARMACEUTICALS, INC.
| MORNINGSIDE CHINA TMT FUND III CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND, L.P.
| MORNINGSIDE CHINA TMT FUND III, L.P.
| MORNINGSIDE CHINA TMT TOP UP FUND LP
| MORNINGSIDE CHINA TMT FUND IV CO-INVESTMENT, L.P.
| MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND II, L.P.
| MORNINGSIDE CHINA TMT FUND IV, L.P.
| ATEA PHARMACEUTICALS, INC.
| GOOD FOODIE CO
| KEZAR LIFE SCIENCES, INC.
| APNIMED, INC.
| STAVROS TECHNOLOGIES, INC.
| STEALTH BIOTHERAPEUTICS CORP
| LUMIRADX LTD
| LINUS HEALTH, INC.
| ANACONDA, INC.
| NEUTROLIS INC.
| COGNITO THERAPEUTICS LTD.
| COGNITO THERAPEUTICS GROUP, INC.
BIHUA
CHEN
DIRECTOR
CORMORANT GLOBAL HEALTHCARE FUND, LP
| CORMORANT GLOBAL HEALTHCARE OFFSHORE FUND, LTD.
| APELLIS PHARMACEUTICALS, INC.
| C4 THERAPEUTICS, INC.
| CORMORANT PRIVATE HEALTHCARE FUND I, LP
| TP THERAPEUTICS, INC.
| TP THERAPEUTICS, INC
| KEZAR LIFE SCIENCES, INC.
| ATEA PHARMACEUTICALS, INC.
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND II, LP
| CORMORANT PRIVATE HEALTHCARE FUND II, LP
| ATIA VISION, INC.
| SUPIRA MEDICAL, INC.
| CORMORANT PRIVATE HEALTHCARE FUND III LP
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND III LP
| ADONA MEDICAL, INC.
| BLOSSOMHILL THERAPEUTICS, INC.
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND IV LP
| CORMORANT PRIVATE HEALTHCARE FUND IV LP
| TIOGA CARDIOVASCULAR, INC.
| BIVACOR INC.
| CHROMA MEDICINE, INC.
| BIOVENTRIX INC
| TIGER BIOTHERAPEUTICS INC.
| CORMORANT PRIVATE HEALTHCARE FUND V LP
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND V LP
| GRAVITON BIOSCIENCE CORP
| INTERIUS BIOTHERAPEUTICS, INC.
| CORMORANT PRIVATE HEALTHCARE FUND VI, LP
| CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND VI, LP
| AKURA MEDICAL, INC.
MICHAEL
KAUFFMAN
DIRECTOR
CHRISTOPHER
J.
KIRK
EXECUTIVE OFFICER, DIRECTOR
JEAN-PIERRE
SOMMADOSSI
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
